Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NJ › Manahawkin › NPI 1831601590
Hospital

HMH Hospitals Corporation

HMH Hospitals Corporation was paid $34.80M by Medicaid between May 2018 and Dec 2024, across 252 billing codes. Its largest line is 99284, emergency room visit (serious) — 26% of everything it billed.

33Billing provider infoHMH HOSPITALS CORPORATION
MANAHAWKIN, NJ 08050
33aNPI1831601590assigned 11/02/2017
28Total paid$34.80M
24GClaims697,160
24DCodes billed252
24AFirst – last monthMay 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in New Jersey

Rank by total paid#44 of 93
Median peer was paid$30.60M
This provider vs. median1.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official HAND, RICHARD controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201832,691$1.95M
201985,525$5.43M
202082,120$4.41M
2021109,899$5.44M
2022130,517$5.94M
2023140,427$6.38M
2024incomplete115,981$5.24M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 26% 25,977 23,111 $9.07M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 25% 29,054 26,952 $8.59M
G0378 Hospital observation service, per hour 8.4% 3,169 2,723 $2.92M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 4.5% 5,978 5,494 $1.58M
99282 Emergency department visit for the evaluation and management, low to moderate severity 4.2% 7,998 7,597 $1.47M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 3.6% 1,377 765 $1.25M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 2.7% 1,097 1,043 $927K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 2.5% 20,339 4,475 $887K
96375 Therapeutic injection; each additional sequential IV push 1.7% 10,770 8,739 $579K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.4% 548 532 $498K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1.2% 10,638 2,668 $427K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.2% 16,281 14,245 $404K
240 more codes
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.1% 3,742 $372K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.0% 4,235 $362K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 13,304 $312K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 5,147 $264K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 3,847 $250K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,732 $235K
70450 Computed tomography, head or brain; without contrast material <1% 5,484 $217K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 327 $216K
96361 Intravenous infusion, hydration; each additional hour <1% 8,679 $200K
80053 Comprehensive metabolic panel <1% 37,469 $192K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 409 $185K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 4,144 $169K
OP370 <1% 2,973 $166K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 2,754 $157K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 6,436 $131K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,131 $125K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 39,667 $125K
71046 Radiologic examination, chest; 2 views <1% 8,162 $109K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 6,711 $104K
71045 Radiologic examination, chest; single view <1% 9,625 $86K
95819 <1% 117 $85K
OP272 <1% 4,491 $82K
OP250 <1% 47,956 $80K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 7,901 $79K
92587 <1% 398 $79K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,137 $79K
93971 <1% 777 $73K
97162 <1% 1,204 $67K
OP710 <1% 1,229 $65K
92567 <1% 574 $59K
90791 Psychiatric diagnostic evaluation <1% 3,953 $57K
97010 <1% 12,793 $55K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 1,052 $48K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 1,113 $45K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,519 $45K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,111 $45K
92557 <1% 153 $43K
36415 Collection of venous blood by venipuncture <1% 34,289 $42K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 4,096 $42K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 5,680 $35K
84484 <1% 9,313 $34K
76830 Ultrasound, transvaginal <1% 796 $28K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 19 $25K
81025 <1% 13,898 $25K
OP279 <1% 2,328 $25K
95886 <1% 90 $25K
71275 Computed tomographic angiography, chest, with contrast material <1% 440 $25K
96376 <1% 2,269 $24K
88313 <1% 1,078 $24K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 3,283 $21K
81003 <1% 13,090 $21K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,118 $21K
83690 <1% 10,372 $20K
82077 <1% 5,123 $19K
96367 <1% 124 $19K
72125 Computed tomography, cervical spine; without contrast material <1% 619 $19K
73630 <1% 1,860 $18K
80048 Basic metabolic panel (calcium, ionized) <1% 3,497 $18K
83735 <1% 6,781 $18K
76819 Fetal biophysical profile; without non-stress testing <1% 263 $17K
73610 <1% 1,617 $15K
84443 Thyroid stimulating hormone (TSH) <1% 4,064 $14K
OP258 <1% 22,087 $14K
85610 <1% 5,989 $14K
83880 <1% 2,254 $13K
36591 <1% 114 $13K
88312 <1% 1,005 $13K
73130 <1% 1,466 $13K
74019 <1% 1,329 $11K
81001 <1% 10,480 $10K
73030 <1% 1,149 $10K
0012A <1% 365 $10K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,415 $10K
85730 <1% 3,679 $10K
99213 Doctor's office visit, returning patient (routine) <1% 76 $10K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 8,079 $10K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,600 $9K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 194 $9K
86901 <1% 1,896 $9K
86900 <1% 1,876 $9K
0011A <1% 349 $9K
82962 <1% 4,845 $9K
OP259 <1% 6,807 $8K
87070 <1% 3,036 $8K
OP379 <1% 298 $8K
82550 <1% 2,963 $8K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 16 $8K
86885 <1% 1,319 $8K
73562 <1% 843 $8K
85027 <1% 2,194 $8K
74018 <1% 885 $8K
73110 <1% 703 $8K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 201 $7K
97163 <1% 108 $7K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,936 $7K
80143 <1% 1,976 $7K
80179 <1% 1,899 $6K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 6,079 $6K
J2704 Injection, propofol, 10 mg <1% 3,269 $6K
87040 <1% 847 $6K
97161 <1% 111 $6K
84100 <1% 3,013 $6K
90715 <1% 620 $6K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,089 $6K
85379 <1% 2,326 $6K
83605 <1% 2,287 $6K
80061 Lipid panel <1% 1,617 $6K
59025 Fetal non-stress test <1% 16 $5K
73502 <1% 401 $5K
72110 <1% 369 $5K
J2060 Injection, lorazepam, 2 mg <1% 2,557 $5K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,831 $5K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,670 $4K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 231 $4K
0064A <1% 126 $4K
J3490 Unclassified drugs <1% 1,165 $4K
71250 <1% 55 $4K
77067 Screening mammography, bilateral, including computer-aided detection <1% 41 $4K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,810 $4K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 536 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 7,849 $3K
72100 <1% 312 $3K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 81 $3K
J1644 Injection, heparin sodium, per 1000 units <1% 1,045 $3K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,198 $3K
87088 <1% 852 $3K
J7050 Infusion, normal saline solution, 250 cc <1% 347 $3K
80306 <1% 1,124 $3K
73564 <1% 153 $3K
84702 <1% 728 $3K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,604 $3K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 1,092 $2K
C9113 Injection, pantoprazole sodium, per vial <1% 1,739 $2K
0002A <1% 62 $2K
82728 <1% 545 $2K
76770 <1% 70 $2K
OP270 <1% 1,084 $2K
80320 <1% 396 $2K
0004A <1% 51 $2K
74021 <1% 210 $2K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 13 $2K
0001A <1% 42 $2K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 39 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,328 $2K
93970 <1% 15 $1K
97035 <1% 538 $1K
83789 <1% 747 $1K
84145 <1% 220 $1K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 117 $1K
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program <1% 539 $1K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 30 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 752 $1K
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 403 $1K
83550 <1% 520 $1K
87077 <1% 681 $1K
87186 <1% 362 $1K
J3360 Injection, diazepam, up to 5 mg <1% 529 $1K
83036 Hemoglobin; glycosylated (A1C) <1% 1,047 $1K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 15 $1K
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 15 $1K
C9290 Injection, bupivacaine liposome, 1 mg <1% 37 $1K
83540 <1% 540 $1K
73080 <1% 122 $1K
0071A <1% 25 $996.05
82248 <1% 277 $915.43
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 355 $802.69
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 53 $733.45
76775 <1% 29 $726.48
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 134 $711.26
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 134 $702.30
88304 <1% 124 $628.39
12001 <1% 29 $620.15
29515 <1% 61 $554.16
90792 Psychiatric diagnostic evaluation with medical services <1% 32 $522.17
J7030 Infusion, normal saline solution , 1000 cc <1% 243 $513.20
73590 <1% 41 $508.86
74220 <1% 17 $475.82
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,034 $453.63
72052 <1% 27 $407.86
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 28 $357.68
87999 <1% 229 $347.52
87420 <1% 211 $333.68
85651 <1% 206 $327.30
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 236 $327.08
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 258 $305.89
80164 <1% 46 $288.75
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 18 $287.50
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,790 $258.64
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 39 $253.55
82607 <1% 87 $247.35
29125 <1% 69 $228.61
A9585 Injection, gadobutrol, 0.1 ml <1% 13 $216.49
72040 <1% 12 $175.49
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 39 $158.88
87581 <1% 30 $152.00
87486 <1% 30 $152.00
J3486 Injection, ziprasidone mesylate, 10 mg <1% 14 $142.94
84439 <1% 211 $140.07
83615 <1% 68 $139.77
J3475 Injection, magnesium sulfate, per 500 mg <1% 46 $138.83
73090 <1% 27 $132.14
J7510 Prednisolone oral, per 5 mg <1% 652 $132.11
85378 <1% 133 $127.09
82378 <1% 21 $119.32
J0690 Injection, cefazolin sodium, 500 mg <1% 174 $112.39
82150 <1% 129 $108.47
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 38 $95.71
82570 <1% 104 $93.62
86618 <1% 13 $91.14
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg <1% 119 $89.56
86308 <1% 141 $82.17
87205 <1% 54 $81.20
82247 <1% 17 $80.03
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 134 $78.46
86140 <1% 69 $74.12
82140 <1% 25 $72.64
J1650 Injection, enoxaparin sodium, 10 mg <1% 83 $69.88
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 135 $67.70
J1790 Injection, droperidol, up to 5 mg <1% 50 $66.80
J3480 Injection, potassium chloride, per 2 meq <1% 60 $65.68
82803 <1% 14 $53.65
OP637 <1% 8,525 $44.73
J1630 Injection, haloperidol, up to 5 mg <1% 107 $41.95
84703 <1% 27 $35.67
80076 <1% 33 $35.12
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 29 $33.80
J2470 Injection, pantoprazole sodium, 40 mg <1% 129 $13.10
J3590 Unclassified biologics <1% 64 $12.00
J1171 Injection, hydromorphone, 0.1 mg <1% 32 $5.06
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 18 $3.35
87147 <1% 12 $3.00
91306 <1% 123 $1.00
91300 0% 180 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 0% 39 $0.00
Q0245 Injection, bamlanivimab and etesevimab, 2100 mg 0% 18 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 13 $0.00
J1815 Injection, insulin, per 5 units 0% 26 $0.00
91301 0% 632 $0.00
91307 0% 69 $0.00
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 0% 118 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHAND, RICHARD (SVP - FINANCE)
Same official

Other billing entities under HAND, RICHARD

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.